Viewing Study NCT01457508


Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2026-03-04 @ 2:59 PM
Study NCT ID: NCT01457508
Status: COMPLETED
Last Update Posted: 2017-06-16
First Post: 2011-10-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module